<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.5: Senolytic Strategies and Cellular Senescence</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GOLD theme for Advanced Modules */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
        }

        /* Content Elements */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #1e3a8a;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
            text-align: center;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            display: block;
        }

        .stat-label {
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Table Style */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
            border-radius: 10px;
            overflow: hidden;
            box-shadow: 0 4px 15px rgba(0,0,0,0.05);
        }

        th {
            background: #1e3a8a;
            color: white;
            padding: 15px;
            text-align: left;
            font-size: 14px;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            font-size: 15px;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f0f9ff;
            border-radius: 8px;
            margin-top: 10px;
            color: #1e3a8a;
            font-style: italic;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 600px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: Advanced Longevity Interventions</p>
            <h1 class="lesson-title">Lesson 5: Senolytic Strategies and Cellular Senescence</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Deep Dive Series</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#biology"><span class="section-num">1</span>The Biology of Zombie Cells</a></li>
                <li><a href="#sasp"><span class="section-num">2</span>Understanding SASP</a></li>
                <li><a href="#natural"><span class="section-num">3</span>Natural Senolytic Compounds</a></li>
                <li><a href="#pharma"><span class="section-num">4</span>Pharmaceutical Frontiers</a></li>
                <li><a href="#autophagy"><span class="section-num">5</span>Autophagy vs. Apoptosis</a></li>
                <li><a href="#protocol"><span class="section-num">6</span>Clinical Implementation</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define cellular senescence and the mechanisms behind the "Zombie Cell" phenomenon.</li>
                <li>Analyze the components of the Senescence-Associated Secretory Phenotype (SASP) and its role in inflammaging.</li>
                <li>Evaluate the evidence for natural senolytics including Fisetin, Quercetin, and Piperlongumine.</li>
                <li>Review the longevity data surrounding Rapamycin and Metformin as senostatic agents.</li>
                <li>Distinguish between cellular cleanup (autophagy) and programmed cell death (apoptosis) in longevity coaching.</li>
            </ul>
        </div>

        <h2 id="biology">1. The Biology of 'Zombie Cells': A Stalemate in Cellular Aging</h2>
        <p>In our previous deep dives into epigenetic clocks, we explored how DNA methylation tracks biological time. However, the physical manifestation of that time often resides in <span class="highlight">cellular senescence</span>. Originally identified by Leonard Hayflick in 1961, cellular senescence is a state where a cell permanently stops dividing but remains metabolically active.</p>

        <p>Under normal conditions, a cell that has reached its "Hayflick Limit" or sustained significant DNA damage should undergo <span class="highlight">apoptosis</span> (programmed cell death). However, senescent cells develop "pro-survival pathways" (SCAPs) that allow them to resist death. They linger in the tissues, earning their nickname: <strong>Zombie Cells</strong>.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">50-70</span>
                    <span class="stat-label">Hayflick Limit (Divisions)</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">20%</span>
                    <span class="stat-label">Senescence in Aged Tissue</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">10x</span>
                    <span class="stat-label">Inflammatory Output</span>
                </div>
            </div>
        </div>

        <p>While senescence is a protective mechanism against cancer (preventing damaged cells from replicating), the accumulation of these cells as we age becomes a primary driver of systemic decline. A 2021 study published in <em>Nature</em> demonstrated that transplanting even a small number of senescent cells into young mice was sufficient to cause physical dysfunction and spread senescence to healthy tissues.</p>

        <h2 id="sasp">2. SASP: The Engine of Inflammaging</h2>
        <p>The danger of zombie cells isn't just their presence; it's their <strong>Senescence-Associated Secretory Phenotype (SASP)</strong>. Senescent cells secrete a toxic cocktail of pro-inflammatory cytokines, chemokines, and proteases that "poison" the surrounding cellular environment.</p>

        <p>Key components of SASP include:</p>
        <ul>
            <li><strong>Interleukin-6 (IL-6) & IL-1Î²:</strong> Potent drivers of systemic inflammation.</li>
            <li><strong>Matrix Metalloproteinases (MMPs):</strong> Enzymes that break down the extracellular matrix, leading to skin aging and joint degradation.</li>
            <li><strong>TNF-Î±:</strong> A signaling protein involved in systemic inflammation and acute phase reactions.</li>
        </ul>

        <p>Through SASP, a single senescent cell can induce senescence in its neighborsâ€”a phenomenon known as the <span class="highlight">bystander effect</span>. This creates a feedback loop of chronic, low-grade inflammation, often referred to as <strong>Inflammaging</strong>, which we discussed in the Gut-Aging Connection (Module 2).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Addressing the SASP Load</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size: 13px;">Inflammaging & Joint Mobility</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James D., Age 62</h4>
                        <p>Symptoms: Chronic stiffness, elevated hs-CRP (4.2 mg/L), and "brain fog."</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Under the A.G.E.L.E.S.S. Protocolâ„¢, James integrated a "Senolytic Pulse" involving high-dose Fisetin (20mg/kg) for two consecutive days, repeated monthly for three months, alongside Zone 2 training to stimulate mitochondrial turnover.</p>
                <p><strong>Outcome:</strong> After 90 days, James reported a 40% reduction in perceived joint stiffness. Follow-up bloodwork showed hs-CRP dropped to 1.8 mg/L. His biological age (via PhenoAge) decreased by 2.4 years.</p>
            </div>
        </div>

        <h2 id="natural">3. Natural Senolytics: Fisetin, Quercetin, and Beyond</h2>
        <p>Senolytics are compounds that selectively induce death in senescent cells by temporarily disabling their pro-survival pathways. Unlike traditional supplements that require daily dosing, senolytics are often used in a "hit-and-run" strategy.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Compound</th>
                        <th>Mechanism of Action</th>
                        <th>Key Evidence (Human/Animal)</th>
                        <th>Coaching Note</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Fisetin</strong></td>
                        <td>Inhibits PI3K/AKT/mTOR pathways</td>
                        <td>Reduced senescence markers in adipose tissue (Mayo Clinic study).</td>
                        <td>Often dosed at 1000mg-2000mg for 2 days.</td>
                    </tr>
                    <tr>
                        <td><strong>Quercetin</strong></td>
                        <td>Targets BCL-2 pro-survival proteins</td>
                        <td>Synergistic with Dasatinib; improves physical function.</td>
                        <td>Found in onions/apples; requires high doses for senolysis.</td>
                    </tr>
                    <tr>
                        <td><strong>Piperlongumine</strong></td>
                        <td>Induces ROS in senescent cells</td>
                        <td>Selectively kills senescent fibroblasts in vitro.</td>
                        <td>Derived from Long Pepper; emerging research.</td>
                    </tr>
                    <tr>
                        <td><strong>Luteolin</strong></td>
                        <td>Inhibits SASP secretion</td>
                        <td>Reduces IL-6 and TNF-Î± production.</td>
                        <td>More "senomorphic" (suppresses SASP) than senolytic.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>The <span class="highlight">Mayo Clinic Protocol</span> for Fisetin is currently the gold standard in human trials (n=40). It utilizes a high-dose pulse (approx. 20mg per kg of body weight) to clear the "zombie cell" load without interfering with the beneficial roles of healthy cell division.</p>

        <h2 id="pharma">4. Pharmaceutical Frontiers: Rapamycin and Metformin</h2>
        <p>While natural compounds are accessible, the longevity community focuses heavily on two pharmaceutical interventions: <strong>Rapamycin</strong> and <strong>Metformin</strong>. These are often classified as <span class="highlight">senostatics</span>â€”compounds that prevent cells from becoming senescent or suppress their toxic output.</p>

        <h3>Rapamycin: The mTOR Inhibitor</h3>
        <p>Rapamycin is currently the most effective pharmacological intervention for extending lifespan in every animal model tested. A 2023 meta-analysis showed that Rapamycin increased median lifespan in mice by <span class="stat-highlight">15-25%</span>. It works by inhibiting <strong>mTORC1</strong>, the master regulator of cell growth. By slowing down the "growth" signal, cells have more time for repair, preventing the transition into a senescent state.</p>

        <h3>Metformin: The AMPK Activator</h3>
        <p>Metformin, traditionally a Type 2 Diabetes drug, is being studied in the TAME (Targeting Aging with Metformin) trial. It activates <strong>AMPK</strong>, which inhibits the NF-ÎºB pathwayâ€”the primary driver of SASP production. Data from the UK Biobank involving over 70,000 participants suggested that diabetics on Metformin actually lived <em>longer</em> than non-diabetics not on the drug.</p>

        <h2 id="autophagy">5. Autophagy vs. Apoptosis: Maximizing Cellular Cleanup</h2>
        <p>As a Longevity Coach, it is vital to distinguish between these two "cleanup" mechanisms to guide client lifestyle choices effectively.</p>

        <div class="principle-card">
            <div class="principle-title">Autophagy (The "Recycling" Center)</div>
            <div class="principle-text">
                Autophagy is an intracellular process where the cell breaks down damaged organelles and proteins to reuse their parts. It is a <strong>repair</strong> mechanism.
                <ul>
                    <li>Triggered by: Fasting (16-48 hours), Exercise, Heat stress.</li>
                    <li>Goal: Make the existing cell healthier.</li>
                </ul>
            </div>
        </div>

        <div class="principle-card" style="border-left-color: #dc2626;">
            <div class="principle-title">Apoptosis (The "Demolition" Crew)</div>
            <div class="principle-text">
                Apoptosis is the programmed death of the entire cell. Senolytics trigger apoptosis specifically in cells that are too damaged to function (Zombie Cells).
                <ul>
                    <li>Triggered by: Senolytic compounds, severe DNA damage.</li>
                    <li>Goal: Remove the cell entirely to make room for new stem-cell-derived cells.</li>
                </ul>
            </div>
        </div>

        <p>In the A.G.E.L.E.S.S. Protocolâ„¢, we utilize <strong>Autophagy</strong> daily/weekly (via time-restricted feeding and Zone 2 exercise) and <strong>Senolysis</strong> quarterly or bi-annually (via targeted supplementation) to maintain tissue integrity.</p>

        <h2 id="protocol">6. Clinical Implementation & The A.G.E.L.E.S.S. Roadmap</h2>
        <p>Coaching clients on senolytics requires a nuanced approach. Because senescent cells play a role in wound healing and tissue repair, <strong>continuous suppression is not advised</strong>. This is why "Pulse Dosing" is the preferred methodology.</p>

        <p>Recommended sequence for advanced clients:</p>
        <ol class="content-list">
            <li><strong>Assessment:</strong> Check hs-CRP and GlycA (an advanced marker of systemic inflammation). High levels may indicate a high senescent load.</li>
            <li><strong>Priming:</strong> Ensure the client has adequate glutathione levels and liver support before initiating a senolytic pulse.</li>
            <li><strong>The Pulse:</strong> Use Fisetin or Quercetin/Bromelain combinations for 48 hours.</li>
            <li><strong>The Rebuild:</strong> Following a pulse, focus on high-quality protein and resistance training to stimulate stem cell proliferation and replace the cleared cells.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Why is it counterproductive to take senolytic supplements like Fisetin every single day?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Senescent cells have a temporary beneficial role in wound healing and tissue remodeling. Continuous use could impair these natural processes. "Pulse dosing" mimics the natural cycle of clearance and regeneration.</p>
            </div>
            <div class="question-item">
                <p class="question-text">What is the primary difference between a senolytic and a senomorphic?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">A senolytic kills the senescent cell (apoptosis), while a senomorphic suppresses the toxic secretions (SASP) of the cell without killing it.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Zombie Cells</strong> are senescent cells that refuse to die, accumulating with age and poisoning healthy tissue.</li>
                <li><strong>SASP</strong> is the "toxic cocktail" of inflammation (IL-6, TNF-Î±) secreted by these cells, driving inflammaging.</li>
                <li><strong>Fisetin</strong> is currently the most researched natural senolytic for human "pulse" protocols.</li>
                <li><strong>Rapamycin</strong> targets the mTOR pathway to prevent cells from entering senescence in the first place.</li>
                <li><strong>Strategic Timing</strong> is essential; senolytic interventions should be pulsed, not continuous, to allow for healthy tissue repair.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Kirkland, J. L., & Tchkonia, T. (2020). "Senolytic drugs: from discovery to translation." <em>Journal of Internal Medicine</em>.</li>
                <li>Yousefzadeh, M. J., et al. (2018). "Fisetin is a senotherapeutic that extends health and lifespan." <em>EBioMedicine</em>.</li>
                <li>Xu, M., et al. (2018). "Senolytics improve physical function and increase lifespan in old age." <em>Nature Medicine</em>.</li>
                <li>Mannick, J. B., et al. (2014). "mTOR inhibition improves immune function in the elderly." <em>Science Translational Medicine</em>.</li>
                <li>Justice, J. N., et al. (2019). "Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study." <em>EBioMedicine</em>.</li>
                <li>Campisi, J. (2013). "Aging, cellular senescence, and cancer." <em>Annual Review of Physiology</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Logo" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Advanced Longevity Certification | Module 13 | Lesson 5</p>
        </footer>
    </div>
</body>

</html>